# Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease

> **NCT01410435** · PHASE3 · COMPLETED · sponsor: **Pharmacosmos A/S** · enrollment: 39 (actual)

## Conditions studied

- Inflammatory Bowel Disease
- Anaemia

## Interventions

- **DRUG:** Monofer

## Key facts

- **NCT ID:** NCT01410435
- **Lead sponsor:** Pharmacosmos A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2013-08
- **Final completion:** 2013-09
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2013-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01410435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01410435, "Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01410435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*